Key Statistics for RBXY
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (INR) (ttm)
|Est. EPS (INR) (12/2013)
|Est. PEG Ratio
|Market Cap (M INR)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (INR)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for RBXY
- Net Income (M/INR)
Ranbaxy Laboratories Limited manufactures and distributes a wide range of pharmaceutical products. The Company makes multisource antibiotics, analgesics, anti-inflammatory drugs and anti-ulcerant/gastrointestinal drugs such as "Roscillin" (Ampicillin), "Cifran" (Ciprofloxacin) and "Sporidex" (Cephalexin).
More Company Profile & Key Executives for RBXY
|Tsutomu UneChairman||Arun SawhneyCEO/Managing Director|
|Indrajit BanerjeePresident/CFO||Sudershan K AroraPres:Research & Dev|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries